| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |